As the 2019 year comes to an end, we would like to recognize the substantial charitable contributions made by the Richmond Pharmacology team; including our staff, academic partners, collaborators and volunteers.Various initiatives have been undertaken including homeless sleep outs, bake sales, marathon events and Christmas Jumper day; all to raise money for those less fortunate than ourselves.

We would like to personally thank two very special volunteers, who decided to donate the payment they received from their study participants to the British Heart Foundation.At Richmond Pharmacology, our ethos is to improve the standard of living for millions of people through our research.

It is through generous donations, initiatives, and partnerships like these, that we are able to achieve our mission.

Notable donations throughout the year have been made to the following Charities

Looking to next year, 2020 promises to be another exciting year for Richmond Pharmacology and we look forward to continuing our charitable endeavors.Read letter of thanks from Robes

Latest news

Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease

June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
Read more

A first of a kind trial in the fight against malaria

June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read more

Events

AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event